Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age50-80
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

This study aims to evaluate the efficacy, safety, and potential mechanisms of prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts.

Researchers will compare prednisolone acetate eye drops to sodium hyaluronate eye drops to see if prednisolone acetate eye drops work to relieve intraoperative and postoperative pain during second-eye cataract surgery.

Participants will:

1. Receive prednisolone acetate eye drops or sodium hyaluronate eye drop four drops within 2 hours before cataract surgery 2. Finish cataract surgery and routine postoperative follow-up 3. Pain questionnaire completed after cataract surgery

Eligibility criteria

Qualifiers

Age between 50-80 years old;

A clear diagnosis of age-related cataract, having completed the first eye cataract surgery at our hospital, and planning to have the second eye cataract surgery with the same doctor;

The interval between the two surgeries is ≤30 days;

Capable of cooperating to complete iris optical coherence tomography angiography examination;

Disqualifiers

History of ocular trauma, ocular surgery, uveitis, fundus disease, glaucoma, or recent history of episcleritis, keratitis, severe dry eye, and other ocular surface disease episodes;

Participation in intraocular or systemic medication clinical trials within the past 6 months;

Having an autoimmune disease or currently undergoing immunosuppressive therapy;

Having a psychiatric disorder such as anxiety or depression;

Trial design

Treatments tested in this trial

  • Prednisolone acetate eye drop group
  • Sodium hyaluronate eye drops

Treatment groups

70 Participants
are divided into 2 treatment groups

Locations

This trial has no locations